Plavix Patient Sues After Suffering Gastrointestinal Bleeding


Plavix Patient Sues After Suffering Gastrointestinal BleedingOverview: Another Plavix user is claiming that the blood thinner caused injuries, and is pursuing litigation. According to the lawsuit, which was filed by the national law firm of Parker Waichman LLP, Plavix caused the Plaintiff to experience gastrointestinal hemorrhaging and other subsequent complications.

Product: Plavix (clopidogrel)  

Manufacturer: Sanofi-Aventis, Bristol-Myers Squibb Co.

Side Effects & Complications 

  •       Cerebral hemorrhage
  •       Thrombotic Thrombocytopenic Purpura (TTP)
  •       Gastrointestinal bleeding
  •       Ulcers
  •       Internal bleeding
  •       Bone marrow damage
  •       Heart attack
  •       Stroke
  •       Death

The Lawsuit

According to a press release by Parker Waichman, the Plaintiff took Plavix for about seven years. The lawsuit alleges that use of the drug caused gastrointestinal hemorrhaging, along with other severe and permanent injuries. The lawsuit also claims that the Defendants, Bristol-Myers Squibb Company and Sanofi-Aventis U.S., L.L.C, failed to inform users about the safety of taking Plavix, including the increased risk of heart attack, stroke, internal bleeding, blood disorders and death.

The suit also alleges that the Defendants falsely marketed Plavix by promoting it as a better option over Aspirin in preventing atherosclerotic events. According to the lawsuit, the Defendants used this marketing strategy even though the U.S. Food and Drug Administration (FDA) gave specific orders not to do so. Furthermore, the suit states, studies suggest that Aspirin is just as effective as Plavix.


Plavix was approved in 1997 to prevent blood clots and ischemic events in high-risk patients. As of 2010, Plavix sales reached $6.1 billion in the US and 9.1 billion worldwide. The blood thinner is relatively pricey at the cost of about $4 per day. Aspirin, on the other hand, costs about four cents a day.